Analysis of natural products improved Nrf2 selectivity with reduced toxicity, highlighting data mining for insights.
This study provides a comprehensive resource for large-scale analysis of natural product selectivity toward Nrf2-related targets. It includes molecular docking results, physicochemical properties, and cheminformatic annotations for 628,898 natural products screened against three key proteins: KEAP1 (Nrf2 regulator), PXR (Pregnane X Receptor), and CYP2D6 (Cytochrome P450 2D6). Each compound entry contains KEAP1, PXR, and CYP2D6 docking scores (karma_score, karma_score_ff, and karma_score_aligned), together with calculated selectivity indices (NSI, SI, and CSS), molecular descriptors (e.g., MW, LogP, TPSA, Fsp³, aromatic ring count), and drug-likeness metrics (QED, Lipinski’s violations). Chemical classifications from the COCONUT database are also included, covering hierarchical taxonomies (superclass, class, subclass) and NP Classifier biosynthetic pathway annotations. The dataset thus integrates structural, functional, and toxicological dimensions into a unified framework suitable for data mining, model development, and cross-study benchmarking.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: